| To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305 (NCT00689247) | AstraZeneca | 2008-04-01 |
| Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients (NCT00866424) | Xijing Hospital | 2008-04-01 |
| Caffeine and Cocaine (NCT00733993) | Virginia Commonwealth University | 2008-04-01 |
| High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma (NCT00761384) | Lund University Hospital | 2008-04-01 |
| Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers (NCT02244190) | Boehringer Ingelheim | 2008-04-01 |
| CEP-701 (Lestaurtinib) in Myelofibrosis (NCT00668421) | Ronald Hoffman | 2008-04-01 |
| Study of ESBA105 Eye Drops in Healthy Subjects (NCT00671619) | ESBATech AG | 2008-04-01 |
| Phase 1 Safety and Immunogenicity of Meningococcal Vaccine (NCT00678652) | U.S. Army Medical Research and Development Command | 2008-04-01 |
| Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects (NCT00672399) | AstraZeneca | 2008-04-01 |
| The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects (NCT00655746) | Bristol-Myers Squibb | 2008-04-01 |
| A Randomized Controlled Trial of a Water Protocol for Clients With Thin Liquid Dysphagia (NCT00616512) | University of British Columbia | 2008-04-01 |
| Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug (NCT00645021) | Pfizer | 2008-04-01 |
| A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma (NCT00658749) | Altair Therapeutics, Inc. | 2008-04-01 |
| Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy (NCT00811408) | Gustave Roussy, Cancer Campus, Grand Paris | 2008-04-01 |
| Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine (NCT00664417) | Sanofi | 2008-04-01 |
| Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL (NCT00655837) | Seagen Inc. | 2008-04-01 |
| A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma (NCT00661336) | Duke University | 2008-04-01 |
| Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males (NCT00676117) | AstraZeneca | 2008-04-01 |
| Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD) (NCT00655993) | VA Loma Linda Health Care System | 2008-04-01 |
| A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness (NCT00654550) | OcuNexus Therapeutics, Inc. | 2008-04-01 |
| A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma (NCT00668499) | University of Southern California | 2008-04-01 |
| Trial of Leptin Administration After Roux-en-Y Gastric Bypass (NCT00710814) | Columbia University | 2008-04-01 |
| Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers (NCT00631995) | Sanofi Pasteur, a Sanofi Company | 2008-04-01 |
| Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy (NCT00665106) | Santen SAS | 2008-04-01 |
| A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration. (NCT00721344) | Mannkind Corporation | 2008-04-01 |
| A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED) (NCT00757601) | Merck Sharp & Dohme LLC | 2008-04-01 |
| VAS-2 Vasectomy With the Vax-X (NCT00663533) | University of Washington | 2008-04-01 |
| Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers (NCT02183441) | Boehringer Ingelheim | 2008-04-01 |
| Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 (NCT00659893) | Peplin | 2008-04-01 |
| GW823296 Repeat Dose Study In Healthy Male And Female Subjects (NCT00675116) | GlaxoSmithKline | 2008-04-01 |
| A Novel Treatment for Metastatic Melanoma (NCT00758797) | Northwestern University | 2008-04-01 |
| Minocycline for HIV+ Cognitive Impairment in Uganda (NCT00855062) | Johns Hopkins University | 2008-04-01 |
| Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers (NCT00818194) | Astellas Pharma Inc | 2008-04-01 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising of BEA 2180 BR in Japanese Healthy Male Volunteers (NCT02254109) | Boehringer Ingelheim | 2008-04-01 |
| Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS) (NCT00782561) | Kyntra Bio | 2008-04-01 |
| Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects (NCT00777530) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-04-01 |
| Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) (NCT00667615) | Memorial Sloan Kettering Cancer Center | 2008-04-01 |
| HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) (NCT01266720) | Fukushima Medical University | 2008-04-01 |
| Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067 (NCT02071810) | Bial - Portela C S.A. | 2008-04-01 |
| Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) (NCT00688207) | GlaxoSmithKline | 2008-04-01 |
| Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors (NCT00661414) | Lpath, Inc. | 2008-04-01 |
| A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia (NCT00530127) | ApoPharma | 2008-04-01 |
| A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya (NCT00666380) | U.S. Army Medical Research and Development Command | 2008-04-01 |
| Neulasta in Type 1 Diabetes (NCT00662519) | University of Florida | 2008-04-01 |
| Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed Condition (NCT01053338) | Dr. Reddy's Laboratories Limited | 2008-04-01 |
| Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis (NCT00743262) | Atos Medical AB | 2008-04-01 |
| Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies (NCT00669097) | Novartis Pharmaceuticals | 2008-04-01 |
| Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves (NCT00665132) | Bioness Inc | 2008-04-01 |
| Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions (NCT01372982) | Dr. Reddy's Laboratories Limited | 2008-04-01 |
| A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer (NCT00627627) | MedImmune LLC | 2008-04-01 |
| Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation (NCT00628550) | University of Texas Southwestern Medical Center | 2008-04-01 |
| Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination (NCT00688428) | AstraZeneca | 2008-04-01 |
| A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer (NCT01062620) | Axelar AB | 2008-04-01 |
| Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning (NCT00664196) | Roger Williams Medical Center | 2008-04-01 |
| Bioequivalence Study of ARQ 197 Amorphous and Crystalline Polymorphs A and B in Normal Healthy Volunteers (NCT00658554) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2008-04-01 |
| Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men (NCT00649701) | Public Health Solutions | 2008-04-01 |
| Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer (NCT00677924) | Genmab | 2008-04-01 |
| Study to Compare Different Formulations of AZD3355 (NCT00688402) | AstraZeneca | 2008-04-01 |
| Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy (NCT00602277) | National Cancer Institute (NCI) | 2008-04-01 |
| Use of Ranibizumab With Mitomycin C During Trabeculectomy (NCT00661583) | University of Colorado, Denver | 2008-04-01 |
| AZD6140 Oral Contraceptive Interaction Study (NCT00685906) | AstraZeneca | 2008-04-01 |
| Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage (NCT00770718) | University of Utah | 2008-04-01 |
| CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I (NCT00661453) | University of Utah | 2008-04-01 |
| A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib (NCT00513253) | GlaxoSmithKline | 2008-04-01 |
| A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers (NCT01565343) | Avid Radiopharmaceuticals | 2008-04-01 |
| Study of MLN4924 in Adult Patients With Nonhematologic Malignancies (NCT00677170) | Millennium Pharmaceuticals, Inc. | 2008-04-01 |
| The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy (NCT00849537) | Shahid Beheshti University of Medical Sciences | 2008-04-01 |
| A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands (NCT00657774) | SkyePharma AG | 2008-04-01 |
| Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial (NCT00815776) | Ascentia Health, Inc. | 2008-04-01 |
| Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa (NCT00691587) | Humanigen, Inc. | 2008-04-01 |
| A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer (NCT00831636) | Clavis Pharma | 2008-04-01 |
| Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors (NCT00675350) | ChemGenex Pharmaceuticals | 2008-04-01 |
| A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure (NCT00662753) | George Washington University | 2008-04-01 |
| Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. (NCT00656734) | Bristol-Myers Squibb | 2008-04-01 |
| Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors (NCT00622414) | National Cancer Institute (NCI) | 2008-04-01 |
| Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer (NCT00702182) | National Cancer Centre, Singapore | 2008-04-01 |
| A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe (NCT00681525) | Abbott | 2008-04-01 |
| Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects (NCT00684710) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-04-01 |
| Serum-Free Thymus Transplantation in DiGeorge Anomaly (NCT00849888) | Sumitomo Pharma Switzerland GmbH | 2008-04-01 |
| Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds (NCT00874094) | The New York Eye & Ear Infirmary | 2008-04-01 |
| Phase I/IIa Study of FIXFc in Hemophilia B Patients (NCT00716716) | Bioverativ Therapeutics Inc. | 2008-04-01 |
| Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma (NCT00667420) | Massachusetts General Hospital | 2008-04-01 |
| Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus (NCT00637338) | Pfizer | 2008-04-01 |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function (NCT02191228) | Boehringer Ingelheim | 2008-04-01 |
| Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer (NCT00702572) | Milton S. Hershey Medical Center | 2008-04-01 |
| Topical Application of MyoRx (Omega 3 Fatty Acids Containing) Cream (NCT00690625) | University of Washington | 2008-04-01 |
| Investigating the Acute Effects of THC on Functional Brain Systems (NCT00628706) | UMC Utrecht | 2008-04-01 |
| A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis (NCT00533091) | MedImmune LLC | 2008-04-01 |
| Everolimus and Capecitabine in Patients With Advanced Malignancy (NCT01079702) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2008-04-01 |
| Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer (NCT00691379) | Hellenic Oncology Research Group | 2008-04-01 |
| An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT00674102) | Novartis Pharmaceuticals | 2008-04-01 |
| A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer (NCT00664170) | Mast Therapeutics, Inc. | 2008-04-01 |
| Cardiac Safety of Indacaterol (NCT01263808) | Novartis Pharmaceuticals | 2008-04-01 |
| Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus. (NCT00671671) | Pfizer | 2008-04-01 |
| Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma (NCT00671554) | Prisma Health-Upstate | 2008-04-01 |
| First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects (NCT01261767) | Novo Nordisk A/S | 2008-04-01 |
| Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug (NCT00644839) | Pfizer | 2008-04-01 |
| Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors (NCT00569036) | Bristol-Myers Squibb | 2008-04-01 |
| Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study (NCT00676559) | Johns Hopkins University | 2008-04-01 |
| Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B (NCT02458092) | U.S. Army Medical Research and Development Command | 2008-04-01 |